New options for therapeutic revascularization in lower extremity limb ischemia linked to the diabetic foot syndrome by autologous stem cell transplantation
Authors:
Jakub Svěcený 1; Eva Syková 2; Michal Tichý 3; Jiří Laštůvka 1
Authors place of work:
Všeobecná interna, Krajská zdravotní, a. s. – Masarykova nemocnice v Ústí nad Labem, o. z.
1; Ústav experimentální medicíny AV ČR, v. v. i.
2; Gastroenterologické oddělení, Krajská zdravotní, a. s. – Masarykova nemocnice v Ústí nad Labem, o. z.
3
Published in the journal:
Čas. Lék. čes. 2015; 154: 161-167
Category:
Review Article
Summary
Type 2 diabetes incidence is growing worldwide. It is in up to 50% cases linked with diabetic foot syndrome. This is associated with peripheral neuropathy and peripheral artery disease which increases risk of defects with impaired healing. Resulting high number of amputations has major influence on the quality of life and constitutes serious clinical issue. In recent years numerous clinical studies have shown positive effect of new treatment modality using regenerative potential of the autologous stem cells transplantation. This review tries to summarize existing results of therapeutic revascularization using stem cell and to outline mechanism of their action.
Keywords:
lower extremity limb ischemia – stem cells – critical limb ischemia – diabetes mellitus
Zdroje
1. International Working Group on the Diabetic Foot (1999). In: International consensus on the diabetic foot. International Working Group on the Diabetic Foot, The Netherlands, 20–96.
2. Procházka V, Gumulec J, Jalůvka V, et al. Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant 2010; 19: 1413–1424.
3. Diaweb.cz. Standardy léčby pacientů se syndromem diabetické nohy [online] [cit. 2014-04-02]. Dostupné na: http://www.diab.cz/dokumenty/dianoha.pdf.
4. Jirkovská A. Syndrom diabetické nohy. Praha: Maxdorf 2010; 134–147, 160–165, 260–265.
5. Čechurová D, Rušavý Z, Lacigová S, et al. Využití transkutánního kyslíku u syndromu diabetické nohy [online] [cit. 2014-03-02]. Dostupné na: http://www.hpb.cz/index.php?pId=03-1-04.
6. Peregrin JH, Kožnar B. Angioplastika bércových tepen. In: Jirkovská A. Syndrom diabetické nohy. Komplexní lékařská péče. Praha: Maxdorf 2006: 134–147.
7. Piťhová P. Syndrom diabetické nohy – závažná komplikace diabetes mellitus. Dermatol Prax 2007; (3–4): 144–148.
8. Pompers L, Schaper N, Apelquist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 2008; 51(5): 747–755 [online] [cit. 2014-04-06]. Dostupné na: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292424/.
9. Leung PC. Diabetic foot ulcers -a comprehensive review. Surgeon 2007; 5(4): 219–231.
10. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360(9331): 427–435.
11. Procházka V, Gumulec J, Chmelová J, et al. Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot. Vnitř Lék 2009; 55(3): 173–178.
12. Bartsch T, Brehm M, Zeus T, et al. Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study). Clin Res Cardiol 2007; 96(12): 891–899.
13. Huang P, Li S, Han M, et al. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 2005; 28(9): 2155–2160.
14. Kudo FA, Nishibe T, Nishibe M, Yasuda K. Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia. Int Angiol 2003; 22(4): 344–347.
15. Dubský M, Jirkovská A, Bém R, et al. Terapie kritické končetinové ischemie u pacientů se syndromem diabetické nohy pomocí autologních kmenových buněk. Vnitř Lék 2011; 57(5): 451–455.
16. Lawall H, Bramlage P, Amann B. Treatment of peripheral arterial disease using stem and progenitor cell therapy. J Vasc Surg 2011; 53(2): 445–453.
17. Kajiguchi M, Kondo T, Izawa H, et al. Safety and efficacy of autologou progenitor cell transplantation for therapeutic angiogenesis on patiens with critical limb ischemia. Circ J 2007; 71(2): 196–201.
18. Amann B, Luedemann C, Ratei R, Schmidt-Lucke JA. Autologous bone marrow cell transplantation increases leg perfusion and amputations in patiens with advanced critical limb ischemia due to peripheral artery disease. Cell Transplant 2009; 18(3): 371–380.
19. Hofírek I, Kořístek M, Navrátil J, et al. Pacienti s diabetickou nohou čtyři roky po transplantaci kmenových buněk. DMEV 2009; 12(Suppl 1): 52 [online] [cit. 2014-04-02]. Dostupné na: http://www.tigis.cz/images/stories/DMEV/2009/suppl_1/05_abstrakta_posteru_dmev_s1-09.pdf
20. Dubsky M, Jirkovska A, Bem R, et al. Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatement. Diabetes Metab Res Rev 2013; 29(5): 369–376.
21. Wahlberg E. Angiogenesis and arteriogenesis in limb ischaemia. J Vasc Surg 2003; 38(1): 198–203.
22. Syková E, Jendelová P, Růžičková K. Kmenové buňky a regenerativní medicína. In: Molekulární medicína a biotechnologie.Soubor přednášek. Praha: Galén 2008: 155–174.
23. Higashi Y, Kimura M, Hara K, et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilatation in patients with limb ischemia. Circulation 2004; 109(10): 1215–1218.
24. Ulicna M, Danisovic L, Vojtassak J. Does cell therapy and tissue engineering represent a promising treatment of diabetic foot ulcers. Bratislavské Lékařské Listy 2010; 111(3): 138–143.
25. Al Mheid I, Quyyumi AA. Cell therapy in peripheral arterial disease. Angiology 2008; 59(6): 705–716.
26. Sprengers RW, Lips DJ, Moll FL, Verhaar MC. Progenitor cell therapy in patiens with critical limb ischemia without surgical options. Ann Surg 2008; 247(3): 411–420.
27. Mulder GD, Lee DK, Jeppesen NS. Comprehensive review of the clinical application of autologous mesenchymal stem cells in the treatment of chronic wounds and diabetic bone healing. Int Wound J 2012; 9(6): 595–600.
28. Kmenové buňky: Ischemická choroba dolních končetin. Dostupné na: http://www.fno.cz/ustav-radiodiagnosticky/kmenove-bunky.
29. Dubský M, Jirkovská A, Bém R, et al. Perspektivy terapie kmenovými buňkami u syndromu diabetické nohy [online] [cit. 2014-04-02]. Dostupné na: http://www.hpb.cz/index.php?pId=08-4-10.
30. Attanasio S, Snell J. Therapeutic angiogenesis in the management of critical limb ischemia: current comcepts and review. Cardiol Rev 2009; 17(3): 115–120.
31. Debin Lu, Bing Chen, Ziwen Liang et al. Comparision of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and food ulcer: A double-blind, randomized, controlled trial. Diabetes Res Clin Pract 2011; 92: 26–36.
32. Keats EC, Khan ZA. Vascular stem cells in diabetic complications: evidence for role in the pathogenesis and the therapeutic promise. Cardiovasc Diabetol 2012; 11: 37.
33. Yang M, Sheng L, Zhang TR, Li Q. Therapy for Lower Extremity Diabetic Ulcers: Where do we stand? BioMed Res Int 2013; 2013: doi:10.1155/2013/462179.
34. Dash SN, Dash NR, Guru B, Mohapatra PC. Towards reaching the target: clinical aplication of mesenchymal stem cells for diabetic foot ulcers. Rejuvenation Res 2014; 17: 40–53.
35. Dubský M, Jirkovská A, Bém R, et al. Možnosti buněčné terapie ICHDK u syndromu diabetické nohy. DMEV 2009; 12(3): 128–132.
36. Kirana S, Stratmann B, Prante C. Autologous stem cell therapy in the treatement of limb ischemia induced chronic tissue ulcers of diabetic foot patients. J Clin Pract 2012; 66(4): 384–393.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- Gastric lavage after peroral intoxication – controversial views
- The story of Appendix
- A short history of infectious diseases since the fifties of the last century and the importance of vaccination
- IgA Nephropathy. Facts, uncertainties, and potential causal therapy approaches